Ann: IHL initiates psilocybin clinical trial for anxiety disorder, page-73

There will always be obstacles to development but these are changing rapidly. Only 3 years ago cannabis was still largely frowned upon and now in the US it is on the verge of decriminalisation and the TGA have just introduced the first guidelines around schedule 3.

Opioids were the pharmaceutical gold standard for pain relief and now they are banned.

There's a reason why these psychedelic stocks are going mental overseas - there is a serious change coming. I think you have to appreciate here how important the psychotherapy is here and not the drug in isolation.

This is where IHL will be so far in front of anyone else here in Australia IMO.

These are mind altering drugs and a lot of the research to date blows away conventional drug treatment and hence why I believe "big Pharma" would be concerned.

Ted